Showing results (91-100 of 221) with videos related to

Sort By:
Pageof 23
International Journal of Obesity (2005)|October 19, 2005
A polymorphism in the adiponectin gene influences adiponectin expression levels in visceral fat in obese subjectsJ Fredriksson, E Carlsson, M Orho-Melander, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|December 1, 1996
Circulating TNF-alpha and leptin levels in offspring of NIDDM patients do not correlate to individual insulin sensitivityM Kellerer, K Rett, W Renn, et al.
European Journal of Epidemiology|October 17, 2002
Classifying diabetes according to the new WHO clinical stagesE Lindholm, E Agardh, T Tuomi, et al.
Diabetologia|January 1, 1984
Roles of chlorpropamide, alcohol and acetaldehyde in determining the chlorpropamide-alcohol flushL Groop, C J Eriksson, R Huupponen, et al.
Diabetologia|June 25, 2005
Heritability of model-derived parameters of beta cell secretion during intravenous and oral glucose tolerance tests: a study of twinsM Lehtovirta, J Kaprio, L Groop, et al.
The American Journal of Clinical Nutrition|February 1, 1992
Effects of weight loss on substrate oxidation, energy expenditure, and insulin sensitivity in obese individualsA Franssila-Kallunki, A Rissanen, A Ekstrand, et al.
Annals of Clinical Research|August 1, 1982
The influence of rapid changes in blood glucose on glycosylated hemoglobin measured by microcolumn and macrocolumn chromatographyL Groop, L Maukonen, K Alopaeus, et al.
Primary Care Diabetes|January 30, 2014
Ethnicity is an independent risk indicator when estimating diabetes risk with FINDRISC scores: a cross sectional study comparing immigrants from the Middle East and native SwedesL Bennet, L Groop, U Lindblad, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 1, 2008
Immigrants from the Middle-East have a different form of Type 2 diabetes compared with Swedish patientsF Glans, T Elgzyri, N Shaat, et al.
Journal of Internal Medicine|August 3, 2006
Glycaemic and nonglycaemic effects of pioglitazone in triple oral therapy of patients with type 2 diabetesM Dorkhan, M Magnusson, A Frid, et al.
Pageof 23